Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Our principles, goals, and beliefs form the foundation of everything we do, shaping a patient experience that goes beyond injections to foster a sense of belonging and empowerment
Retatrutide (LY-3437943) is an investigational drug developed by Eli Lilly that acts as a triple hormone receptor agonist : GLP-1 (glucagon-like peptide-1) receptor agonist GIP (glucose-dependent insulinotropic polypeptide) receptor agonist Glucagon receptor agonist - read about why this is so important here This triagonist approach amplifies the metabolic impact seen with GLP-1 and GIP combinations like tirzepatide, while also leveraging glucagons thermogenic and energy-expending properties
Do Not Use Carnitine If You Have Decreased Liver Functioning
It is not recommended during breastfeeding
US$ 25.38
US$ 24.23
US$ 20.15
US$ 26.12
